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Abstract
Bakground: The goal of our study was to test the relative
stability of urine, unconjugated, free catecholamines and the
methyl derivatives. We measured the change in concentra-
tions in commercially available urines after storage at various
pH values, temperatures and time, from days up to 10 weeks.
Methods: Samples of commercial control urines were
adjusted to pH 2.0, 4.0, 6.0 and 8.0 and aliquots stored at
ambient temperature (20–268C), 48C and –18oC. The free
catecholamines (cats) and the free methyl derivatives (mets)
were measured after 1, 2, 3 and 6 days and 1, 2, 3 and
10 weeks using the automated sample trace enrichment dial-
ysis (ASTED) procedure with reversed phase ion pair high
performance liquid chromatography (HPLC) and coulometric
detection.
Results: Free catecholamines were relatively stable, with
-15% loss of concentration, when stored at pH 6.0 or less
for at least 4 days and up to 10 weeks at pH 2.0 at either
4oC or –18oC. At pH 8.0, the concentration fell to -60%
after 48 h and at a pH of 6.0 or 8.0, up to 90% was lost
within the first week at 4oC and 25oC. More than 40% of
free normetadrenaline and metadrenaline were lost after
1–2 weeks when stored at 20–25oC and pH 8.0. After
10 weeks at pH 4.0, 6.0 and 8.0, up to 90% loss was
observed at 25oC. Free cats were stable at pH 2.0 and 4.0 at
–18oC and the free mets were stable at –18oC over the entire
time period studied and at all pHs.
Conclusions: In the analysis of free catecholamine and the
free methyl derivatives, urine samples should be acidified to
a pH range 2.0–3.0 to ensure stability and hence the correct
analysis.
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Introduction
The measurement of the free (non-conjugated) or total (com-
bination of the free and conjugated) individual catechola-
mines (cats) and/or the total individual methylated
derivatives (mets) is well established for the detection of
tumours that secrete catecholamines in urine (1–3) or in plas-
ma (4). Recently, measurement with on line clean up wauto-
mated sample trace enrichment dialysis (ASTED)x and ion
pair based separation of the free methylated compounds was
suggested to be at least as good as total individual mets and/
or free unconjugated parent (cats), or possibly a better alter-
native (5). Over the past several years, we have successfully
used the ASTED procedure for the measurement of both the
free parent and methylated derivatives. We have always
observed good concordance between the two; if one is
increased the other is also increased (6). However, cases that
break the rules can always be found. For example, normal
cats raised mets and normal cats and mets with increased
vanillylmandelic acid (VMA) (7). As many analytes as pos-
sible are used to catch all the possible scenarios, although
for the diagnosis of phaechromocytoma, urinary free meta-
drenalines have been shown to demonstrate superior clinical
sensitivity over plasma or urinary catecholamines or urinary
VMA (8). Also, we have confirmed the importance and ben-
efit of simultaneous measurement of dopamine, which can
be increased in ;3% of urines from adults with catechola-
mine secreting tumours (9, 10). A recent review on tumours
that secrete catecholamines suggested that metadrenalines in
urine or plasma are the most likely to be abnormal (11).
However, this is clearly not correct in patients with tumours
that secrete dopamine only, or its metabolites (9, 10).
The underlying problem for all these analyses is the integ-
rity/dependability of the sample. Catecholamines are sensi-
tive to oxidation, particularly at greater than neutral pHs
where the well described adenochrome-like compounds are
formed from adrenaline and noradrenaline, and dopachrome
from dopamine (12). Thus, it is imperative that low pHs of
-4.0, and preferably -3.0 are used, along with an antiox-
idant for long-term storage. A major confounding variable
in the diagnostic value of urinary free cats is changes due to
oxidative decay; a loss of as little as 20%–30% can result in
abnormal values being reported as normal. This is another
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Table 1 Analytical characteristics of free catecholamines and free methyl derivatives in commercial quality control urine.
Analyte, nmol/L Noradrenaline Adrenaline Normetadrenaline Metadrenaline Dopamine
Lypho 1 250 74 1385 362 552
(210–290) (54–94) (1125–1645) (262–462) (452–652)
7.0% 9.6% 8.3% 11% 7.4%
Lypho 2 1158 466 7878 2850 3124
(1028–1278) (386–546) (6478–9278) (2210–3490) (2624–3624)
4.8% 6.7% 7.3% 9% 5.7%
BioRad HPLC
Level 1 284 93 1911 598 601
(213–355) (60–126) (1420–2402) (446–750) (451–751)
Level 2 1229 502 8518 3093 3461
(969–1489) (393–612) (6825–10,210) (2459–3726) (2612–4310)
Lypho 1 and 2 values are nmol/L as mean and in parentheses ( ) ranges observed over a 6-month period (ns20); the CV% quoted is
between batch precision analysis. The BioRad (Lypho) HPLC values are those given by the manufacturer showing the target mean and
range of acceptable results in ( ) and indicate similar values to those analysed. The slightly lower values for the Lypho 1 normetadrenaline
and metadrenaline probaly related to the amount of endogenous sulpho complex not measured.
reason why measurement of mets is preferred, as they are
apparently much less likely to degrade at neutral pH. A
recent study (13) of stability over 7 days indicated that the
parent catecholamines are relatively unstable in unacidified
urines, losing more than 50% of their initial concentration.
However, total (free plus conjugated) methyl compounds
remained stable over the 7 days. These findings have been
confirmed several times, in particular for the non-methylated
and unconjugated parent compounds (14, 15). However,
from our own experience in the measurement of the uncon-
jugated free compounds, it is often observed that low cats
are present with low mets in unacidified urine with pHs up
to pH 8.0. This finding suggests that free mets are not as
stable as predicted.
If the assay of the free compounds, particularly free mets
becomes more widespread, it is important to have good ana-
lytical data on their relative stabilities in urine. Our goal was
to reassess the stability in urine of both unconjugated free
and methylated compounds, over a pH range of 2.0, 4.0, 6.0
and 8.0, temperatures of –18oC, 4oC and room temperature
(20–26oC), and over a long period of time (days up to
10 weeks). We chose a reference urine material so that we
could be certain of the concentrations (added in as the free
metabolites) and little variation in antioxidants such as vita-
min C that could affect stability.
Materials and methods
All chemicals used were of Analar grade and solutions were pre-
pared using doubly deionised water (Ultra Q, Elga Products, High
Wycombe, UK).
Urine Lypho I and II (Lyphocheck, Urine Quality Controls,
BioRad Laboratories, Hemel Hempstead, UK) were used for com-
parative purposes, with the stated and laboratory measured concen-
trations for the relevant analytes shown in Table 1. The commercial
urine samples were spiked with unconjugated mets. The values
quoted in Table 1 for the BioRad high performance liquid chro-
matography (HPLC) are total methylcated derivatives and include
any residual urine derivative compounds; hence the slight discrep-
ancy between the stated values and our measured concentrations.
Aliquots of these urines were prepared at various pH values 2.0,
4.0, 6.0 and 8.0 by the addition of small amounts of 4 M sulphuric
acid (H2SO4), or 4 M sodium hydroxide (NaOH). The amounts add-
ed did not cause any significant dilutional effects. However, to avoid
any misinterpretation due to dilution, data were expressed as percent
of the analysis obtained at day 0. The samples were stored at ambi-
ent room temperature (20–26oC), 4oC and –18oC and analysed on
days 0, 2, 4, and 6 and weeks 1, 2, 3 and 10.
Separate aliquots were measured for the free catecholamines,
noradrenaline, adrenaline and dopamine, and the free methyl deriv-
atives (mets) normetadrenaline and metadrenaline. The analysis (16)
of all these separate compounds was achieved using ion pair HPLC
on a 15 cm Spherisorb 5 octadodecyl silanyl (ODS) (2) after auto-
mated sample preparation (ASTED) and detection by coulometry
(Coulochem, ESA Analytical Ltd., Aylesbury, UK).
The actual analytical between batch imprecision for each analyte
in Table 1 was between 4.8% and 11%, with an average of ;7.5%.
A reduction in concentration was regarded as significant if the meas-
ured change was )15%, determined by taking two times the aver-
age CV of 7.5% as a cut-off threshold for significant change. The
data are presented graphically with individual data points to show
changes at the different times and temperatures.
Results
The free catecholamines were relatively stable at pH 6.0 or
less for at least 4 days, with less than a 15% decrease in
concentration as shown in Figures 1–3 (urine Lypho 1 and
2). However, at pH 8.0, the measured concentration fell to
-60% of starting values after 48 h. Even when stored at
–18oC at high pH, the change in concentration was still sig-
nificant with more than 60% loss after 4 days. Studies with
Lypho 2 urine that contained higher amounts, the free cate-
cholamines degraded in similar fashion after 2–3 days at
ambient temperature and pH 8.0. Following 1 week of stor-
age at either pH 6.0 and 8.0, all the free analyte was lost.
There was no significant change in the measured concentra-
tion of free normetadrenaline and metadrenaline over a 7-
day period at any pH when stored at 48C or –18oC. However,
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Figure 1 Change in concentration of noradrenaline in urine Lypho
1 and Lypho 2 after storage up to 7 days at various temperatures
(258C, 48C and –18oC).
Samples kept at pH 2.0 or 4.0 and temperatures of 48C or –18oC
showed no significant change in the measured concentration.
Figure 2 Change in concentration of adrenaline in urine Lypho 1
and Lypho 2 after storage for up to 7 days at various temperatures
258C, 48C and –18oC.
Samples kept at pH 2.0 or 4.0 and temperatures of 48C or –18oC
showed no significant change in the measured concentration.
when stored at pH 8.0 and ambient/room temperature (25oC),
normetadrenaline showed a decrease in concentration of up
to 20% after 7 days, while metadrenaline showed no change
(data not shown).
Studies of longer storage times (Figure 4) showed that free
catecholamines were stable at pH 2.0 and pH 4.0 for up to
10 weeks at either 48C or –18oC. However, at pH 6.0 and
8.0, 90% was lost within the first week at 48C or 25oC.
Marked loss was also observed at pH 4.0 when stored at
25oC for up to 10 weeks.
Free normetadrenaline (Figure 5) showed more than 90%
loss at pH 8.0 when stored at 25oC for 2 weeks, and from
40% to )90% loss at 20oC after 10 weeks at pH 4.0, 6.0 or
8.0. Free metadrenaline (Figure 6) showed more than 75%
loss after 10 weeks at pH 4.0, 6.0 or 8.0 when stored at
25oC.
Fee normetadrenaline and metadrenaline in both Lypho 1
and 2 were stable when stored at –18oC over the entire time
period and at all pH values.
Discussion
This study showed that free catecholamines are relatively
stable over several days and a range of concentrations if the
urine is kept at 4oC and at pH 6.0 or less. This has also been
observed (17) with urine collected in the hospital ward with-
out acid preservative and pH values up to 7.0, as long as
samples were delivered to the laboratory and analysed imme-
diately or acidified and stored at –18oC prior to analysis. To
ensure stability of free parent and methylated catechola-
mines, we always recommend collecting urine in bottles
containing acid. Following receipt of the sample in the lab-
oratory, the urine pH is checked and acidified if necessary
to at least a pH of 3.0 and stored at –18oC before analysis
within 1–2 weeks. The dependability of sample integrity is
probably one of the confounding variables in the diagnostic
value of free catecholamines, and is one of the major reasons
why measurement of the mets is preferred; they are much
less likely to degrade at neutral pH. However, we have now
shown that the free mets are also prone to degradation if
maintained at high pH and room temperature. Thus, precau-
tion must be taken to avoid loss of these analytes from oxi-
dation. It may of course be that the sulphated forms of the
mets are themselves more stable with long-term storage
regardless of pH, although no studies on this aspect have
been reported.
Studies with individual human samples, as opposed to
commercially available control urine, could be confounded
by the presence of antioxidants such as vitamin C, citric acid
and other amino acids that might act as oxidative scavengers.
This probably explains why the change in urine cats can be
minimal for up to 2 days, even at room temperature (13).
This latter study showed that catecholamines were stable at
pH 7.0 and 4oC, whereas after 7 days at room temperature
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Figure 3 Change in concentration of dopamine in urine Lypho 1
and Lypho 2 after storage for up to 7 days at various temperatures
258C, 48C and –18oC.
Samples kept at pH 2.0 or 4.0 and temperatures of 48C or –188C
showed no significant change in the measured concentration.
(20–25oC) a loss in concentrations of up to 30% was report-
ed. The free catecholamines were relatively stable for a few
days at pH 8.0, but only if kept at 4oC (13). At the extreme
pH of 10.0, catecholamines degraded within a few hours.
Interestingly, at a pH of -1.0, measured free catecholamines
increased up to 50% after 7 days due to hydrolysis of the
conjugated forms (13). Also, over-acidification can cause
urine to become extremely dark in appearance, resulting in
analytical problems due to extraneous peaks on the chro-
matogram. Therefore, it is important not to acidify to a pH
of -2.0.
A recent review (18) on the analysis of urinary catecho-
lamines concluded that any strong acid could be used as long
as the final pH was 3.5 or less. However, for assays using
the ASTED procedure, H2SO4 is recommended as preser-
vative because this acid, unlike hydrochloric acid is non-
oxidising (16). To reduce the risk to patients posed by the
presence of acid in urine collection bottles, the addition of
sand (1 g Sigma grade for a 24-h collection) has been used
to maintain a low urine pH without risks of acid leakage
(18). An alternative to the use of a strong acid preservative
was the use of formate buffer (19) to maintain the urine pH
at ;3.5. Urine catecholamines preserved in this way were
as stable as those in acid preserved urines when stored at
–80oC. However, decrease in concentration of up to 40% was
observed after storage for 8 weeks at 4oC. Alternative sta-
bilising agents such as EDTA or sodium bisulphite could be
used without any loss of activity, as long as samples were
collected and then stored immediately at –18oC before ana-
lyis (13). The effect of physiological temperature should also
not be ignored as urine may reside in the bladder at elevated
pH and 37oC for several hours. Under these conditions, insta-
bility may be increased particularly for the catecholamines
(20). These authors therefore recommended that during urine
collection for measurement of catecholamines, the bladder
should be emptied every 3 h, if possible.
Because of the problems associated with the collection of
urine into acid, there is increasing support for measurement
of methylated catecholamine derivatives as the most appro-
priate – ‘best test’ – for catecholamine secreting tumours.
However, we advise that both types of compounds be meas-
ured, especially considering that the diagnostic features of
these tumours are the excess production of active biogenic
amines, and not the methyl derivatives (21). However, a
recent review on the function and metabolism indicated that
the free methylated compounds may show some physiolog-
ical function (22), whereas sulpho conjugation (the major
urine metabolite) results in complete deactivation of the cat-
echols (23). Of interest is that a significant proportion of
methylation can occur within the adrenal gland and the
tumours themselves, and it is possible to relate the amount
of methyl derivatives that are secreted to tumour size (8, 24).
These arguments support the view that the free species are
the most physiologically relevant and therefore the most
appropriate analytical target.
The value of measurements in plasma (3) of the free non-
and methylated components really depends on improvements
in analytical performance, appropriateness of sample collec-
tion and good renal function. If these conditions can be sat-
isfied, such assays will have marked impact in terms of
convenience to both the patient and laboratory. However, at
this time most laboratories still use urine collection as the
basis in the investigation of tumours that secrete catechola-
mines. Unfortunately, whatever test is used, it is still possible
that both misleading laboratory results combined with clin-
ical investigation including CT and magnetic resonance
imaging (MRI) may miss the tumour or result in the wrong
diagnosis, as shown in a recent review on the diagnosis of
phaechromocytoma (25). The patient’s age may also be a
confounding variable (26). In spite of these issues, a recent
study (27) suggested that plasma free metanephrines are most
likely to confirm the presence of a catecholamine secreting
tumour (being up to 100=normal concentrations), rather
than urine mets, cats or HMMA (4-hydroxy-3-methoxy man-
delic acid). Unfortunately, the concentrations of the separate
mets are still relatively low, requiring up to 1 mL of plasma
for analysis by HPLC, and also can be raised up to 10 times
normal in patients with renal failure. In addition, the analyt-
ical performance at low concentrations can be poor, as seen
in our own experience of an automated plasma catechol-
amine method that used electrochemical detection where the
analytical performance was unpredictable (28). However,
newly developed liquid chromatography-mass spectrometry
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Figure 4 Change in concentration of (A) noradrenaline, (B) adrenaline and (C) dopamine in urine Lypho 1 and Lypho 2 after storage
from 1 to 10 weeks at various pH values and temperatures of 258C, 48C or –188C.
Samples kept at pH 2.0 or 4.0 and temperatures of 48C and –188C showed no significant change in the measured concentration.
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Figure 5 Change in concentration of (A) normetadrenaline at
25oC and (B) normetadrenaline at 48C in Lypho 1 after storage from
1 to 10 weeks.
Lypho 2 showed very similar trends, but data are not shown. Sam-
ples kept at pH 2.0 and or 4.0 and temperatures of 48C and –18oC
showed no significant change in the measured concentration.
Figure 6 Change in concentration of (A) metadrenaline at 25oC
and (B) metadrenaline at 48C and –18oC in Lypho 1 after storage
from 1 to 10 weeks.
Lypho 2 showed very similar trends, but data are not shown. Sam-
ples kept at pH 2.0 or 4.0 and temperatures of 48C and –18oC
showed no significant change in the measured concentration.
(LCMS) techniques require less sample (50–100 mL) and
seem to provide good analytical performance both at normal
and increased values (29). Nevertheless, increased plasma
metanephrines may be misleading in up to 20% of patients
(25). Indeed, a recent review concluded that plasma and
urine free metanephrines should be considered complemen-
tary rather than mutually exclusive (30). Thus, it is important
that the analytical pitfalls, in particular the instability of the
analytes and the need for appropriate collection, are clearly
understood.
In conclusion, we confirmed that free catecholamines can
be stable in urine at a pH of 6.0 (i.e., similar to an unacidified
urine collection) for short periods of time such as 2–3 days,
and particularly if stored at 4oC or –18oC. The free meth-
ylated derivatives are stable for up to 2–3 weeks if stored
under similar conditions, but do degrade if urine is kept at a
high pH of up to 8.0 for several days/weeks, particularly if
left at room temperature. Therefore, to avoid any problems
with analyte instability, it is strongly recommended that 24 h
urines be collected into acid, or to acidify freshly collected
samples to between pH 2.0 and 3.0 and then store at –18oC
prior to analysis. Care must also be taken not to overacidify
samples to a pH of -2.0 to avoid hydrolysis of the conju-
gated compounds. Our view is in agreement with that of
others (5, 8) that analysis of both the free cats, and including
dopamine and free mets will provide the most diagnostically
useful profile.
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